Briefing
TRACERx: preoperative ctDNA below 80 parts per million still marked worse survival in lung adenocarcinoma
In the January 13, 2025 Nature Medicine TRACERx analysis, lung adenocarcinomas with preoperative ctDNA detected below 80 parts per million still had worse overall survival than ctDNA-negative adenocarcinomas (HR 12.33; 95% CI 1.63 to 93.35).